Literature DB >> 10753853

Weak D alleles express distinct phenotypes.

F F Wagner1, A Frohmajer, B Ladewig, N I Eicher, C B Lonicer, T H Müller, M H Siegel, W A Flegel.   

Abstract

The weak D phenotype is caused by many different RHD alleles encoding aberrant RhD proteins, raising the possibility of distinct serologic phenotypes and of anti-D immunizations in weak D. We reported 6 new RHD alleles, D category III type IV, DIM, and the weak D types 4.1, 4.2.1, 4.2.2, and 17. The immunohematologic features of 18 weak D types were examined by agglutination and flow cytometry with more than 50 monoclonal anti-D. The agglutination patterns of the partial D phenotypes DIM, D(III) type IV, and D(IV) type III correlated well with the D epitope models, those of the weak D types showed no correlation. In flow cytometry, the weak D types displayed type-specific antigen densities between 70 and 4000 RhD antigens per cell and qualitatively distinct D antigens. A Rhesus D similarity index was devised to characterize the extent of qualitative changes in aberrant D antigens and discriminated normal D from all tested partial D, including D category III. In some rare weak D types, the extent of the alterations was comparable to that found in partial Ds that were prone to anti-D immunization. Four of 6 case reports with anti-D in weak D represented auto-anti-D. We concluded that, in contrast to previous assumptions, most weak D types, including prevalent ones, carry altered D antigens. These observations are suggestive of a clinically relevant potential for anti-D immunizations in some, but not in the prevalent weak D types, and were used to derive an improved transfusion strategy in weak D patients. (Blood. 2000;95:2699-2708)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753853

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  51 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  The genetics of the Rhesus blood group system.

Authors:  Willy A Flegel
Journal:  Blood Transfus       Date:  2007-04       Impact factor: 3.443

3.  Analysis of density and epitopes of D antigen on the surface of erythrocytes from DEL phenotypic individuals carrying the RHD1227A allele.

Authors:  Juan Gu; An-Yuan Sun; Xue-Dong Wang; Chao-Peng Shao; Zheng Li; Li-Hua Huang; Zhao-Lin Pan; Qing-Ping Wang; Guang-Ming Sun
Journal:  Blood Transfus       Date:  2013-11-21       Impact factor: 3.443

4.  RHD PCR of D-Negative Blood Donors.

Authors:  Franz F Wagner
Journal:  Transfus Med Hemother       Date:  2013-05-08       Impact factor: 3.747

5.  Weak D in the Tunisian population.

Authors:  Mouna Ouchari; Houda Romdhane; Taher Chakroun; Saida Abdelkefi; Batoul Houissa; Slama Hmida; Saloua Jemni Yacoub
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

6.  A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.

Authors:  Willy A Flegel; Thierry Peyrard; Jacques Chiaroni; Christophe Tournamille; Déborah Jamet; France Pirenne
Journal:  Blood Transfus       Date:  2018-05-03       Impact factor: 3.443

Review 7.  Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.

Authors:  S Gerald Sandler; Leonard N Chen; Willy A Flegel
Journal:  Br J Haematol       Date:  2017-05-16       Impact factor: 6.998

8.  A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population.

Authors:  Swati Kulkarni; Vasantha Kasiviswanathan; Kanjaksha Ghosh
Journal:  Blood Transfus       Date:  2012-07-12       Impact factor: 3.443

9.  DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications.

Authors:  Connie M Westhoff; Sunitha Vege; Christine Halter-Hipsky; Trina Whorley; Kim Hue-Roye; Christine Lomas-Francis; Marion E Reid
Journal:  Transfusion       Date:  2010-01-15       Impact factor: 3.157

Review 10.  Genotyping in Sickle Cell Disease Patients: The French Strategy.

Authors:  Aline Floch; Christophe Tournamille; Btissam Chami; France Pirenne
Journal:  Transfus Med Hemother       Date:  2018-07-06       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.